Page last updated: 2024-11-07

methyl-2-acetamido-2-deoxy-d-glucopyranoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methyl-2-acetamido-2-deoxy-D-glucopyranoside: RN given refers to (alpha-D)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID96523
SCHEMBL ID1674288
MeSH IDM0062329

Synonyms (26)

Synonym
6082-04-8
methyl-2-acetamido-2-deoxy-d-glucopyranoside
alpha-d-glucopyranoside, methyl 2-(acetylamino)-2-deoxy-
BMSE000196
methyl-n-acetylglucosamine
n-[(2s,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-methoxyoxan-3-yl]acetamide
methyl 2-acetamido-2-deoxy-|a-d-glucopyranoside
2-[[3-chloro-6-(trifluoromethyl)-2-pyridyl]-methyl-amino]-6-(4-hydroxy-3,5-dimethoxy-phenyl)-8-methyl-3a,4,6,11,11a,11b-hexahydronaphtho[6,7-e]isoindole-1,3,7,10-tetrone
A832904
methyl 2-acetamido-2-deoxy-alpha-d-glucopyranoside
AKOS015919190
nsc 77914
2F8 ,
SCHEMBL1674288
ZEVOCXOZYFLVKN-OKNNCHMLSA-N ,
n-[(2s,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-methoxy-tetrahydropyran-3-yl]acetamide
methyl 2-(acetylamino)-2-deoxy-alpha-d-glucopyranoside
CS-0207169
n-((2s,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-methoxytetrahydro-2h-pyran-3-yl)acetamide
AMY31011
methyl 2-acetamido-2-deoxy-?-d-glucopyranoside
glcnac-a-ome
methyl n-acetyl- alpha -d-glucosaminide
BS-29024
HY-W150693
F71735
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (85.71)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.09 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]